Ríos FBA, Rey UL, Ibarra PJ, Olivas PE

Language: Spanish
References: 23
Page: 360-366
PDF size: 54.82 Kb.

ABSTRACT

Introduction: Seizures are the most frecuent sign of neurologic disfunction in the neonatal period and it could be the only feature of neurologic dysfunction, therefore the importance of its recognizition. The objective of the present study was to define the incidence and characteristics of the neonatal seizures in the Instituto Nacional de Perinatología which is a third level of attention hospital. Material and methods: The present study is retrospective, observational and descriptive. We included all the newborns registered in the labor unit, attended in the intermediate therapy unit . All the patients had fulfilled the inclusion criteria for the present study. Results: The results show a prevalence of 0.89% of seizures; myoclonic typewere the most frequent followed by clonic and tonic seizures. Most patients were treated in monotherapy with Phenobarbital. Discusion: The more prevalent sequels in our patients were epilepsy, neurologic development delay and hypoacusia.

REFERENCES

1. Holmes G, Ben-Ari Y. The neurobiology and consequences of epilepsy in the developing brain. Ped Res 2001; 49: 320-5.

2. Zupanc M. Neonatal seizures. Ped Clin NAM 2004; 51: 45-57.

3. Arzimanoglou A, Guerrini R, Aicardi J. Aicardi´s Epilepsy in children. Philadelphia: Lippincott Williams and Wilkins; 2004.

4. Hahn C, Riviello J. Neonatal seizures and EEG: electroclinical dissociation and uncoupling. Neoreviews 2004; 5: 350-5.

5. Clancy R. Summary proceedings from the neurology group on neonatal seizures. Pediatrics 2006; 117: s23-27.

6. Boylan G, et al. Phenobarbitone, neonatal seizures, and video- EEG. Arch Dis Child Fetal Neonatal Ed 2002; 86: F165-70.

7. Laroia N. Current controversies in diagnosis and management of neonatal seizures. Indian Pediatrics 2000; 37: 367-72.

8. Engel J. Report of the ILAE classification core group. Epilepsia 2006; 47: 1558-68.

9. Da Silva L, Nunes L, Da Costa J. Risk factors for developing epilepsy after neonatal seizures. Ped Neurol 2004; 30: 271-7.

10. Armstrong D, Battin M. Pervasive seizures caused by hypoxic-ischemic encephalopathy: treatment with intravenous paraldehyde. J Child Neurol 2001; 16: 915-17.

11. Booth D, Evans D. Anticonvulsivants for neonates with seizures. Cochrane Database Syst Rev 2004; 18: CD004218.

12. Wirrell E. Neonatal seizures: to treat or not to treat. Semin Pediatr Neurol 2005; 12: 97-105.

13. Boylan G, et al. Second-line anticonvulsant treatment of neonatal seizures. A video EEG monitoring study. Neurology 2004; 62: 486-8.

14. Matheisel A, Beldzinska M, Wendorff J, Cymerman J, Chmielewski R. Topiramate effective as a monotherapy in childhood epilepsy. 25TH International epilepsy congress, Lisboa. Octubre 2003. Abstract.

15. Nagelhus E, et al. Effect of topiramate on continuous spikewaves during slow-wave sleep. 25th International Epilepsy Congress, Lisboa. Octubre 2003. Abstract.

16. Wheless J, Clarke D, Carpenter D. Treatment of pediatric epilepsy: expert opinion. J Child Neurol 2005; 20: s1-56.

17. Pellock J. Antiepileptic drugs trials: neonates and infants. Epilepsy Res 2006; 68: 42-5.

18. Hmaimess G, et al. Levetiracetam in a neonate with malignant migrating partial seizures. Pediatric Neurol 2006; 34: 55-9.

19. Castro J, et al. Midazolam in neonatal seizures with no response to phenobarbital. Neurology 2005; 64: 776-7.

20. Sugiyama N, et al. Efficacy of lidocaine on seizures by intravenous and intravenous-drip infusión. No To Hattatsu 2004; 36: 451-4.

21. Alfonso I, et al. Intravenous valproate dosing in neonates. J Child Neurol 2000; 15: 827-9.

22. McBride M, Laroia N, Guillet R. Electrographic seizures in neonates correlate with poor neurodevelopmental outcome. Neurology 2000; 22; 506:13.

23. Rennie J, Boylan G. Neonatal seizures and their treatment. Curr Opin Neurol 2003; 16: 177-81.